Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer-Reference-Cited by-同舟云学术

Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer

Published:2010-08-19 Issue:18 Volume:116 Page:4318-4325
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Donnem Tom,Al-Shibli Khalid,Andersen Sigve,Al-Saad Samer,Busund Lill-Tove,Bremnes Roy M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25333/fullpdf

Reference21 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin.,2007

2. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline;Pisters;J Clin Oncol.,2007

3. Antibodies to vascular endothelial growth factor in non-small cell lung cancer;Wakelee;J Thorac Oncol.,2008

4. The future of cancer vaccines for non-small-cell lung cancer: ongoing trials;Choudhury;Clin Lung Cancer.,2008

5. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination;van den Heuvel;Clin Lung Cancer.,2009

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck;Brazilian Journal of Otorhinolaryngology;2024-11

2. Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-06-21

3. Attenuated Salmonella-delivered PD-1 siRNA enhances the antitumor effects of EZH2 inhibitors in colorectal cancer;International Immunopharmacology;2023-11

4. New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization;Molecular Diversity;2023-02-15

5. siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing Hepatocellular carcinoma;International Immunopharmacology;2022-10